Cancer/testis antigen 1

DB19291InvestigationalProtein Based Therapies

Cancer/testis antigen 1: Overview.

Mechanism
Curator reviewed
Also known as
Autoimmunogenic cancer/testis antigen ny-eso-1 · Cancer/testis antigen 6.1 · L antigen family member 2
Code names
ESO-1 · LAGE-2 · NY-ESO-1

Resolves to

Compound
UNIIPE5J9IS0ISCAS2259683-77-5
Targets
P01850TRBC1O60449LY75

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
52Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cancer/testis antigen 1, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In